Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Feb 4, 2010 (rev. 1)

Premium

Raindance Technologies said this week that it has appointed Sirshendu Roopom Banerjee as president and CEO.

Banerjee was most recently director of healthcare investment banking at Leerink Swann, where he led the life science tools and diagnostics sector. Previously, Banerjee was with McKinsey and Goldman Sachs, where he advised Fortune 500 healthcare companies on corporate and growth strategy, product development, launch strategy, international expansion, and mergers and acquisitions.

Earlier in his career, Banerjee worked at Dana Farber Cancer Institute, the Whitehead Institute/MIT Human Genome Project, and the Massachusetts General Hospital Cancer Center. He holds a master's degree in public policy from the Kennedy School of Government at Harvard University and dual BS degrees in biology and economics from MIT.

Christopher McNary, who has served as RainDance CEO since Nov. 2007, will become chief commercial officer.

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.